158 related articles for article (PubMed ID: 8690301)
1. [Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice].
Kobayashi M; Shinagawa K; Sugiura M; Nagasawa T; Akahane M; Ajisawa Y
Nihon Yakurigaku Zasshi; 1996 Apr; 107(4):183-95. PubMed ID: 8690301
[TBL] [Abstract][Full Text] [Related]
2. [Effect of KSG-504, a new synthetic cholecystokinin receptor antagonist on ethionine-induced acute pancreatitis in rats].
Okumura Y; Bamba T; Shintani Y; Yoshioka U; Inoue H; Fujiyama Y; Hosoda S
Nihon Shokakibyo Gakkai Zasshi; 1993 Dec; 90(12):3032-40. PubMed ID: 8283814
[TBL] [Abstract][Full Text] [Related]
3. Effect of a new cholecystokinin receptor antagonist (KSG 504) on the early stage of the healing process in acute pancreatitis induced in rats by the closed duodenal loop technique.
Ha S; Satake K; Hiura A; Sowa M; Nishiwaki H
Pancreas; 1994 Jul; 9(4):501-7. PubMed ID: 7524065
[TBL] [Abstract][Full Text] [Related]
4. Effects of short-term administration of the CCK receptor antagonist, KSG-504, on regeneration of pancreatic acinar cells in acute pancreatitis in rats.
Okumura Y; Inoue H; Fujiyama Y; Bamba T
J Gastroenterol; 1995 Aug; 30(4):493-9. PubMed ID: 7550860
[TBL] [Abstract][Full Text] [Related]
5. Effects of KSG-504, a new cholecystokinin-A-receptor antagonist, on pancreatic exocrine and endocrine secretions in rats.
Yamazaki Y; Akahane M; Kobayashi M; Takeda H; Ajisawa Y
Jpn J Pharmacol; 1996 Feb; 70(2):183-90. PubMed ID: 8866756
[TBL] [Abstract][Full Text] [Related]
6. Cytokine level changes in L-arginine-induced acute pancreatitis in rat.
Takács T; Czakó L; Jármay K; Farkas G; Mándi Y; Lonovics J
Acta Physiol Hung; 1996; 84(2):147-56. PubMed ID: 9046361
[TBL] [Abstract][Full Text] [Related]
7. [Behavioral studies of KSG-504, a new CCK-A receptor antagonist].
Yamazaki Y; Takeda H; Akahane M; Tsubaki A; Ajisawa Y
Nihon Yakurigaku Zasshi; 1996 Jan; 107(1):21-31. PubMed ID: 8720295
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of KSG-504, a new cholecystokinin-A-receptor antagonist.
Yamazaki Y; Akahane M; Kobayashi M; Kitazawa M; Kurashina Y; Iizuka K
Jpn J Pharmacol; 1993 Oct; 63(2):219-25. PubMed ID: 7506805
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of L-arginine-induced acute necrotizing pancreatitis: inflammatory mediators and endogenous cholecystokinin.
Czakó L; Takács T; Varga IS; Hai DQ; Tiszlavicz L; Hegyi P; Mándi Y; Matkovics B; Lonovics J
J Physiol Paris; 2000; 94(1):43-50. PubMed ID: 10761688
[TBL] [Abstract][Full Text] [Related]
10. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
11. Different inhibitory effects of the newly developed CCK receptor antagonists FK480 and KSG-504 on pancreatic exocrine and endocrine secretion in the isolated perfused rat pancreas.
Kihara Y; Otsuki M
Pancreas; 1995 Mar; 10(2):109-17. PubMed ID: 7716133
[TBL] [Abstract][Full Text] [Related]
12. [Effects of KSG-504, a new CCK-A receptor antagonist, on gallbladder and gastrointestinal functions].
Yamazaki Y; Akahane M; Kobayashi M; Shinagawa K; Sugiura M; Ajisawa Y
Nihon Yakurigaku Zasshi; 1996 Jan; 107(1):33-44. PubMed ID: 8720296
[TBL] [Abstract][Full Text] [Related]
13. A new CCK-A antagonist, KSG-504, administered intraduodenally, inhibits pancreatic secretion in rats.
Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
Pancreas; 1994 Mar; 9(2):225-9. PubMed ID: 8190724
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin-A specific antagonism of KSG-504 to cholecystokinin receptor binding and pancreatic secretion in mammals.
Yamazaki Y; Shinagawa K; Takeda H; Kobayashi M; Akahane M; Ajisawa Y
Jpn J Pharmacol; 1995 Dec; 69(4):367-73. PubMed ID: 8786640
[TBL] [Abstract][Full Text] [Related]
15. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats.
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
Pancreas; 1998 Oct; 17(3):289-94. PubMed ID: 9788544
[TBL] [Abstract][Full Text] [Related]
16. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
Nakano S; Tachibana I; Otsuki M
Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
[TBL] [Abstract][Full Text] [Related]
17. Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice.
Silverman M; Ilardi C; Bank S; Kranz V; Lendvai S
Gastroenterology; 1989 Jan; 96(1):186-92. PubMed ID: 2462522
[TBL] [Abstract][Full Text] [Related]
18. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic and protective effect of subcutaneous injections of L-364,718 on caerulein-induced acute pancreatitis.
Garcia-Montero AC; Manso MA; Rodriguez AI; De Dios I
Pancreas; 1994 May; 9(3):309-15. PubMed ID: 7517544
[TBL] [Abstract][Full Text] [Related]
20. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
Nakano S; Kihara Y; Otsuki M
Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
